PlainRecalls
FDA Drug Moderate Class II Ongoing

Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03

Reported: May 29, 2024 Initiated: May 10, 2024 #D-0505-2024

Product Description

Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Details

Units Affected
66 bottles of 30 tablets
Distribution
Product distributed to CA, FL, OK, KS and CT
Location
Anaheim, CA

Frequently Asked Questions

What product was recalled?
Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03. Recalled by Preferred Pharmaceuticals, Inc.. Units affected: 66 bottles of 30 tablets.
Why was this product recalled?
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Which agency issued this recall?
This recall was issued by the FDA Drug on May 29, 2024. Severity: Moderate. Recall number: D-0505-2024.